X4 Pharmaceuticals (XFOR) Announces Reverse Stock Split
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/6/2026
- Mahindra & Mahindra Ltd (MM:IN) (MAHMF) PT Raised to INR320 at HSBC
- HSBC Downgrades Shriram Finance Ltd (SHFL:IN) to Hold
- Broadcom, Apple extend chip supply deal through 2031
- Lockheed Martin to acquire Ultra Maritime for $3.45 billion
- Strategy reports $8.32B bitcoin loss and sells BTC to fund dividends
X4 Pharmaceuticals Announces Reverse Stock Split
April 24, 2025 8:00 AM EDTBOSTON, April 24, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that its board of directors has determined to effect a one-for-thirty reverse stock split of the companys Common Stock, par value $0.001 per share.
The reverse... More
